Astera Labs, Inc. (ALAB)
(Delayed Data from NSDQ)
$41.77 USD
+1.99 (4.99%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $41.70 -0.07 (-0.17%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Income Statements
Fiscal Year end for Astera Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 116 | 80 | NA | NA | NA |
Cost Of Goods | 36 | 21 | NA | NA | NA |
Gross Profit | 80 | 59 | NA | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 109 | 119 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -30 | -60 | 0 | 0 | 0 |
Non-Operating Income | 7 | 3 | NA | NA | NA |
Interest Expense | 0 | 0 | NA | NA | NA |
Pretax Income | -23 | -58 | NA | NA | NA |
Income Taxes | 3 | 1 | NA | NA | NA |
Minority Interest | 0 | 0 | NA | NA | NA |
Investment Gains/Losses | 0 | 0 | NA | NA | NA |
Other Income/Charges | 0 | 0 | NA | NA | NA |
Income From Cont. Operations | -26 | -58 | NA | NA | NA |
Extras & Discontinued Operations | 0 | 0 | NA | NA | NA |
Net Income (GAAP) | -26 | -58 | NA | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -29 | -60 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | NA | NA | NA |
Income After Depreciation & Amortization | -30 | -60 | 0 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.71 | NA | NA | NA | NA |
Fiscal Year end for Astera Labs, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 76.85 | 65.26 | NA | NA | 10.69 |
Cost Of Goods | 17.00 | 14.74 | NA | NA | 2.25 |
Gross Profit | 59.85 | 50.52 | NA | NA | 8.44 |
SG&A, R&D, and Dept/Amort Expenses | 84.20 | 133.49 | 0.00 | 0.00 | 26.05 |
Income After SG&A, R&D, and Dept/Amort Expenses | -24.35 | -82.97 | 0.00 | 0.00 | -17.61 |
Non-Operating Income | 10.26 | 2.55 | NA | NA | 1.56 |
Interest Expense | 0.00 | 0.00 | NA | NA | 0.00 |
Pretax Income | -14.08 | -80.41 | NA | NA | -16.06 |
Income Taxes | -6.54 | 12.58 | NA | NA | 3.95 |
Minority Interest | 0.00 | 0.00 | NA | NA | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | NA | NA | 0.00 |
Other Income/Charges | 0.00 | 0.00 | NA | NA | 0.00 |
Income From Cont. Operations | -7.55 | -93.00 | NA | NA | -20.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | NA | NA | 0.00 |
Net Income (GAAP) | -7.55 | -93.00 | NA | NA | -20.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 155.20 | 52.53 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.14 | -1.76 | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.05 | -1.77 | NA | NA | NA |